Informe de análisis del tamaño, la participación y las tendencias del mercado mundial del cannabis medicinal: descripción general de la industria y pronóstico hasta 2031

Análisis del mercado del cannabis medicinal

El mercado del cannabis medicinal ha experimentado un crecimiento significativo en los últimos años, impulsado por el creciente reconocimiento de sus beneficios terapéuticos para diversas afecciones médicas. Con los esfuerzos de legalización ganando impulso en múltiples regiones, la demanda de productos de cannabis medicinal está en aumento. Este mercado abarca una amplia gama de productos, incluidos aceites, cápsulas y comestibles, diseñados para afecciones como el dolor crónico , la epilepsia y los trastornos de salud mental. Los desarrollos recientes, como los avances en las técnicas de cultivo y los procesos de extracción, han mejorado la calidad y la eficacia del producto, lo que ha impulsado aún más la expansión del mercado. Además, la creciente conciencia y aceptación de los consumidores, junto con las políticas gubernamentales de apoyo, son factores clave que contribuyen a la perspectiva positiva del mercado. A medida que la investigación continúa revelando los beneficios potenciales del cannabis, el mercado del cannabis medicinal está preparado para un crecimiento sostenido, ofreciendo nuevas oportunidades tanto para las empresas farmacéuticas como para los proveedores de atención médica.

Tamaño del mercado del cannabis medicinal

El tamaño del mercado mundial de cannabis medicinal se valoró en USD 21.06 mil millones en 2023 y se proyecta que alcance los USD 108.90 mil millones para 2031, con una CAGR del 22,80% durante el período de pronóstico de 2024 a 2031. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Tendencias del mercado del cannabis medicinal

“ Demanda de productos de cannabis personalizados”

The medical cannabis market is witnessing transformative trends driven by innovation and evolving consumer preferences. A notable trend is the growing demand for personalized cannabis products, where consumers seek tailored formulations to address specific health conditions and individual needs. Innovations in cannabis extraction and formulation techniques are enabling the development of diverse product offerings, such as targeted oils and infused edibles, that enhance therapeutic effects. In addition, advancements in technology, including the use of artificial intelligence and data analytics in cultivation and supply chain management, are optimizing production processes and ensuring product consistency. Overall, these trends reflect a shift towards more effective, customized medical cannabis solutions, catering to the diverse needs of patients and driving market growth.

Report Scope and Medical Cannabis Market Segmentation  

Medical Cannabis Market Definition

Medical cannabis refers to the use of the cannabis plant and its derivatives for therapeutic purposes. It encompasses a variety of products, including oils, capsules, tinctures, and topical formulations, containing cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD). Medical cannabis is prescribed to alleviate symptoms associated with various health conditions, including chronic pain, epilepsy, multiple sclerosis, nausea from chemotherapy, and anxiety. Its use is often regulated by laws that vary by region, and it is typically recommended when conventional treatments have proven ineffective.

Medical Cannabis Market Dynamics

Drivers

• Increasing Acceptance and Legalization

The increasing acceptance of medical cannabis among healthcare professionals and medical cannabis patients is a significant driver of market growth. As research continues to unveil the therapeutic benefits of cannabinoids for various medical conditions, healthcare providers are more inclined to recommend cannabis as a treatment option. This shift in perception has led to greater patient awareness and willingness to consider medical cannabis for managing chronic pain, anxiety, and other ailments. Moreover, the legalization of medical cannabis in numerous regions has further facilitated its integration into mainstream healthcare. This regulatory change legitimizes its use and encourages investment in research and product development, thus expanding the market. The combined effect of these factors is expected to foster significant growth in the medical cannabis market.

•  Rising Prevalence of Chronic Diseases

The rising incidence of chronic diseases, including cancer, epilepsy, and multiple sclerosis, has created a substantial demand for effective pain management and therapeutic solutions, significantly boosting the medical cannabis market. Patients suffering from these conditions often experience severe pain, discomfort, and a range of debilitating symptoms that conventional treatments may not adequately address. Medical cannabis, with its diverse array of cannabinoids, offers a natural alternative that can alleviate pain and improve quality of life. As healthcare providers increasingly recognize the potential of cannabis-based treatments, more patients are being referred to medical cannabis as a viable option. This growing acceptance, alongside ongoing research demonstrating the efficacy of cannabis for symptom relief, continues to propel market growth as patients seek effective and holistic approaches to managing their health conditions.

Opportunities

• Integration with Traditional Healthcare

Collaborations between cannabis companies and traditional healthcare providers present a significant opportunity for market growth in the medical cannabis sector. By partnering with healthcare professionals, cannabis companies can enhance the legitimacy of their products and foster trust among potential patients. These collaborations can lead to the development of educational programs and clinical guidelines, making healthcare providers more comfortable recommending cannabis therapies as part of a comprehensive treatment plan. As healthcare providers gain confidence in the efficacy and safety of medical cannabis, they are more likely to advocate for its use, ultimately increasing patient access to these therapies. This integration broadens the market reach of cannabis products and contributes to the overall acceptance of medical cannabis within mainstream healthcare, driving sustained market expansion.

• Advancements in Research and Development

Ongoing research into the therapeutic benefits of cannabinoids is unlocking new opportunities in the medical cannabis market. As scientists and healthcare professionals continue to explore the medicinal properties of various cannabinoids, they are discovering innovative applications for conditions ranging from chronic pain and anxiety to neurological disorders. This research has led to the development of new medical cannabis products, expanding the variety of treatment options available to patients. Such advancements cater to diverse patient needs and enhance the efficacy and safety profiles of cannabis-based therapies. As more clinical studies validate the benefits of these products, they are likely to gain acceptance among healthcare providers and patients alike. This expansion of product offerings presents a lucrative opportunity for companies to capture a larger share of the growing medical cannabis market, ultimately improving patient outcomes and satisfaction.

Restraints/Challenges

• Lack of Standardized Regulations

The medical cannabis market faces significant challenges due to the lack of standardized regulations and the varying legal frameworks across different regions. Each jurisdiction has its own rules governing the cultivation, distribution, and sale of medical cannabis, creating a complex landscape for companies to navigate. This regulatory inconsistency often results in confusion and delays in market entry for new players. Companies may spend considerable time and resources understanding local laws, obtaining necessary licenses, and ensuring compliance with diverse regulations. These hurdles can deter potential investors and limit the growth of the market. Consequently, the absence of a unified regulatory approach poses a significant challenge to the expansion and accessibility of medical cannabis products globally.

•  Competition from Traditional Therapies

Established pharmaceutical treatments continue to hold a significant share of the healthcare market, often backed by extensive research, clinical trials, and regulatory approvals. These conventional therapies are widely prescribed by healthcare professionals and have a long-standing reputation for safety and efficacy. As a result, patients and doctors may be hesitant to consider medical cannabis products as viable alternatives, especially in serious conditions like cancer and chronic pain. The familiarity and trust in traditional medications can hinder the adoption of medical cannabis, despite its potential benefits. This reliance on established treatments limits the market growth for cannabis-based therapies, as healthcare professionals may prioritize familiar pharmaceutical options over newer, less understood cannabis products. This restraint creates a challenge for the medical cannabis market to gain traction among patients and healthcare providers.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Medical Cannabis Market Scope

The market is segmented on the basis of product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Oil
• Medical Cannabis Capsules
• Parche
• Flor entera
• Flor de tierra
• Bolígrafo vaporizador
• Cannabis medicinal seco
• Cremas y humectantes
• Mascarillas y sueros
• Limpiador
• Otros

Fuente

• Natural
• Sintético

Especies

• Cannabis Indica
• Cannabis sativa
• Híbrido

Solicitud

• Enfermedad de Alzheimer
• Pérdida de apetito
• Cáncer
• Enfermedades inflamatorias del intestino
• Trastornos alimentarios
• Epilepsia
• Autismo
• Condiciones de salud mental
• Esclerosis múltiple
• Manejo del dolor
• Náuseas
• Espasmos musculares
• Síndrome de desgaste (caquexia)
• Elevar el estado de ánimo
• Depresión y trastornos del sueño
• Ansiedad
• Otros

Derivados

• Cannabidiol (CBD)
• Tetrahidrocannabinol (THC) / Delta-8-tetrahidrocannabinol
• Cannabinol (CBN)
• Cannabiciclol (CBL)
• Cannabicromeno (CBC)
• Cannabigerol (CBG)
• Otros

Tipo de tratamiento

• Expectorante
• Antivírico
• Analgésico
• Afrodisiaco
• Psicodélico
• Otros

Vía de administración

• Soluciones orales y cápsulas
• De fumar
• Vaporizadores
• Temas tópicos
• Otros

Usuario final

• Industria farmacéutica
• Centros de investigación y desarrollo
• Entorno de atención domiciliaria
• Hospitales
• Centros de rehabilitación
• Otros

Canal de distribución

• B2B
• De empresa a consumidor

 Análisis regional del mercado del cannabis medicinal

Se analiza el mercado y se proporcionan información y tendencias del tamaño del mercado por país, producto, fuente, especie, derivados, aplicación, vía de administración, tipo de tratamiento, usuario final y canal de distribución como se mencionó anteriormente.

Los países cubiertos en el informe de mercado son EE. UU., Canadá y México en América del Norte, Alemania, Francia, Reino Unido, Países Bajos, Suiza, Bélgica, Rusia, Italia, España, Turquía, Resto de Europa en Europa, China, Japón, India, Corea del Sur, Singapur, Malasia, Australia, Tailandia, Indonesia, Filipinas, Resto de Asia-Pacífico (APAC) en Asia-Pacífico (APAC), Arabia Saudita, Emiratos Árabes Unidos, Sudáfrica, Egipto, Israel, Resto de Medio Oriente y África (MEA) como parte de Medio Oriente y África (MEA), Brasil, Argentina y Resto de América del Sur como parte de América del Sur.

Se espera que América del Norte domine el mercado mundial de cannabis medicinal debido a la creciente inversión en cannabis medicinal. Se espera que Estados Unidos domine la región de América del Norte debido a la legalización del uso de cannabis medicinal. Se espera que Alemania domine la región de Europa debido a la creciente demanda de cannabis medicinal en los mercados emergentes y la expansión. Se espera que Australia domine la región de Asia y el Pacífico debido a la presencia de fabricantes clave y procesos tecnológicos avanzados.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Los puntos de datos como el análisis de la cadena de valor aguas abajo y aguas arriba, las tendencias técnicas y el análisis de las cinco fuerzas de Porter, los estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.  

Cuota de mercado del cannabis medicinal

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Medical Cannabis Market Leaders Operating in the Market Are:

• MediPharm Labs Inc. (Canada)
• Tilray (Canada)
• Aurora Cannabis (Canada)
• JAZZ Pharmaceuticals Inc. (U.K.) (GW Pharmaceuticals plc)
• HEXO Corp. (Canada) (Zenabis Global Ltd)
• Cresco Labs (U.S.)
• Peace Naturals Project Inc. (Canada)
• CANOPY GROWTH CORPORATION (Canada)
• Medical Marijuana, Inc. (U.S.)
• Seed Cellar (U.S.)
• EcoGen Biosciences (U.S.)
• CANNABIS SEEDS USA (U.S.)
• Seeds For Me (U.S.)
• HUMBOLDT SEED COMPANY (U.S.)
• Extractas (U.S.)
• World Class Cannabis Seeds (Crop King Seeds) (Canada)
• BARNEY'S FARM (Netherlands)
• FOLIUM BIOSCIENCES (U.S.)
• PharmaHemp (U.K.)
• Elixinol Global Limited (Australia)
• ENDOCA (Netherlands)
• Harmony (U.K.)
• MARY’S Nutritionals, LLC (U.S.)
• Pure Ratios (U.S.)
• Greenwich Biosciences, Inc. (U.S.)
• Upstate Elevator Supply Co. (U.S.)
• Apothecanna (U.S.)
• BOL Pharma (Israel)
• IDT Australia (Australia)

Latest Developments in Medical Cannabis Market

• In February 2023, Aurora Cannabis Inc., a Canadian company specializing in global cannabis distribution, collaborated with MedReleaf Australia to launch CraftPlant, a new medical cannabis brand for the Australian market. The initial offerings from CraftPlant include three products—Greendae, Navana, and HiVolt—all of which are now available for prescription by doctors. Each strain boasts a high THC concentration and is sourced from premium cultivars developed by Occo, Aurora's leading scientific and genetics company, and will be packaged in 10g canisters produced under strict EU-GMP authorized standards
• In July 2023, Carer, an oncology company in India, announced a partnership with Wholeleaf, a certified manufacturer of medicinal cannabis and cannabidiol. This collaboration aims to improve the overall well-being of cancer patients by offering comprehensive support that includes nutrition for caregivers, physical therapy, and mental health services. With official approval from the Ayush ministry to manufacture and market its products nationwide, CARER and Wholeleaf are combining their services to deliver a holistic solution for cancer care
• En septiembre de 2023, Alternaleaf, una clínica reconocida por ayudar a los australianos a obtener cannabis medicinal, anunció su expansión al Reino Unido. Las investigaciones indican que Inglaterra está en camino de convertirse en el segundo mercado más grande de cannabis medicinal en Europa, impulsado por la creciente demanda. Con más de 360.000 casos reportados de adicción a opioides en el Reino Unido, los expertos sugieren que el cannabis medicinal podría servir como una alternativa viable a los opioides, que con frecuencia se recetan innecesariamente.
• En abril de 2022, Medi Cane Health Inc. y Dr. Reddy's Laboratories Ltd. lanzaron su producto de cannabis medicinal en Alemania. Esta colaboración tiene como objetivo satisfacer la creciente demanda de soluciones de cannabis medicinal en la región. La introducción de este producto marca un paso importante en la expansión del acceso a las opciones de cannabis terapéutico para los pacientes en Alemania.
• En abril de 2022, la ciudad de Nueva York fue testigo de sus primeras ventas legales de marihuana, lo que ocurrió apenas un mes después de que siete empresas de marihuana medicinal recibieran la aprobación para vender sus productos a todos los adultos. Este hito significa un cambio significativo en el panorama del cannabis del estado, ampliando el acceso más allá del uso medicinal. La iniciativa tiene como objetivo crear un mercado regulado al tiempo que beneficia a las economías locales y garantiza la seguridad del consumidor.

SKU-52961